[Changes in ASP (antigroup-A streptococcal C polysaccharide antibody) and cardiac and renal effects in cases of urogenital cancers during OK-432 immunotherapy, streptococcus preparation].
Tanji
S
S
Koike
H
H
Kumagai
K
K
Fujioka
T
T
Kubo
T
T
Ohhori
T
T
Yoshida
I
I
D000328:Adult; D000368:Aged; D000907:Antibodies, Bacterial / Q000032:analysis*; D000917:Antibody Formation; D001688:Biological Products / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007668:Kidney / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D010844:Picibanil / Q000627:therapeutic use*; D011135:Polysaccharides, Bacterial / Q000276:immunology*; D014565:Urogenital Neoplasms / Q000276:immunology* / Q000628:therapy
D000907:Antibodies, Bacterial; D001688:Biological Products; D011135:Polysaccharides, Bacterial; C036112:streptococcal polysaccharide group A; D010844:Picibanil